文献速递高血压心力衰竭与心肌病血脂与心血管预防

心脏病孕妇妊娠期高血压疾病:ESC EORP ROPAC登记研究

Hypertensive disorders of pregnant women with heart disease: the ESC EORP ROPAC Registry.
PubMed 文献 · Eur Heart J · 2022-01-01

基于ESC EORP ROPAC全球前瞻性登记中5739例心脏病孕妇,妊娠期高血压疾病(HDP)总体患病率为10.3%,其中慢性高血压5.9%、妊娠期高血压1.3%、子痫前期3%。合并HDP者孕产妇死亡率、心衰及围产期死亡率均升高,子痫前期者孕产妇死亡率达3.5%,且子痫前期相关死亡均为产后发生、50%由心衰导致。

要点

  • 心脏病孕妇HDP总体患病率10.3%,子痫前期3%。
  • 子痫前期者孕产妇死亡率3.5%,心衰发生率达29.1%。
  • HDP合并心脏病应多学科密切监测,子痫前期需住院并持续产后监测。

核心结论

  • 心脏病孕妇中HDP与子痫前期发生率高于一般人群,以心肌病、缺血性心脏病和肺动脉高压者最为突出。
  • 合并HDP者不良结局增加,子痫前期者孕产妇死亡率显著升高。

研究设计与样本

  • ESC EORP ROPAC为全球前瞻性登记,纳入5739例心脏病孕妇,评估HDP(慢性高血压、妊娠期高血压或子痫前期)的患病率与结局。

主要发现

  • HDP总体患病率10.3%,由慢性高血压5.9%、妊娠期高血压1.3%、子痫前期3%构成,不同基础心脏病类型间差异显著(P < 0.05)。
  • 子痫前期发生率在肺动脉高压(PAH)11.1%、心肌病(CMP)7.1%、缺血性心脏病(IHD)6.3%者中最高。
  • 合并与不合并HDP者孕产妇死亡率分别为1.4%与0.6%(P = 0.04),子痫前期者达3.5%。
  • 合并与不合并HDP者心衰发生率分别为18.5%与10.6%(P < 0.001),子痫前期者为29.1%。
  • 合并与不合并HDP者围产期死亡率分别为3.1%与1.7%(P = 0.019),子痫前期者为4.7%。

临床怎么用

  • HDP合并心脏病应启动多学科密切监测。
  • 子痫前期诊断需住院并在产后继续监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Hypertensive disorders of pregnancy (HDP) occur in 10% of pregnancies in the general population, pre-eclampsia specifically in 3-5%. Hypertensive disorders of pregnancy may have a high prevalence in, and be poorly tolerated by, women with heart disease. METHODS AND RESULTS: The prevalence and outcomes of HDP (chronic hypertension, gestational hypertension or pre-eclampsia) were assessed in the ESC EORP ROPAC (n = 5739), a worldwide prospective registry of pregnancies in women with heart disease.The overall prevalence of HDP was 10.3%, made up of chronic hypertension (5.9%), gestational hypertension (1.3%), and pre-eclampsia (3%), with significant differences between the types of underlying heart disease (P < 0.05). Pre-eclampsia rates were highest in women with pulmonary arterial hypertension (PAH) (11.1%), cardiomyopathy (CMP) (7.1%), and ischaemic heart disease (IHD) (6.3%). Maternal mortality was 1.4 and 0.6% in women with vs. without HDP (P = 0.04), and even 3.5% in those with pre-eclampsia. All pre-eclampsia-related deaths were post-partum and 50% were due to heart failure. Heart failure occurred in 18.5 vs. 10.6% of women with vs. without HDP (P < 0.001) and in 29.1% of those with pre-eclampsia. Perinatal mortality was 3.1 vs. 1.7% in women with vs. without HDP (P = 0.019) and 4.7% in those with pre-eclampsia. CONCLUSION: Hypertensive disorders of pregnancy and pre-eclampsia rates were higher in women with CMP, IHD, and PAH than in the general population. Adverse outcomes were increased in women with HDP, and maternal mortality was strikingly high in women with pre-eclampsia. The combination of HDP and heart disease should prompt close surveillance in a multidisciplinary context and the diagnosis of pre-eclampsia requires hospital admission and continued monitoring during the post-partum period.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Ramlakhan KP, Malhamé I, Marelli A, et al. Hypertensive disorders of pregnant women with heart disease: the ESC EORP ROPAC Registry. Eur Heart J. 2022. PMID: 35727736. doi:10.1093/eurheartj/ehac308

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。